Cetrotide 0.25’mg Injection
Cetrotide 0.25 mg is a medication used to prevent early release of eggs in women undergoing IVF treatment. It is given as a daily injection under the skin, usually for a few days during the ovarian stimulation cycle. Cetrotide helps control the timing of egg maturation and release to optimize the chances of successful egg retrieval and fertilization. It is used together with other fertility medications.
In pregnancy
Cetrotide (cetrorelix) should not be used during pregnancy.
Administration
Cetrotide is administered by subcutaneous injection into the lower abdomen. The recommended dose is 0.25 mg given once daily, typically starting on day 5-6 of ovarian stimulation and continuing until the day of ovulation induction. The first dose should be given under medical supervision in case of allergic reactions. Subsequent doses can be self-administered by the patient, rotating the injection site each day.
Original price was: ₨6,499.00.₨5,999.00Current price is: ₨5,999.00.
Description
Cetrotide 0.25 mg is a medication used to prevent early release of eggs in women undergoing IVF treatment. It is given as a daily injection under the skin, usually for a few days during the ovarian stimulation cycle. Cetrotide helps control the timing of egg maturation and release to optimize the chances of successful egg retrieval and fertilization. It is used together with other fertility medications.
In pregnancy
Cetrotide (cetrorelix) should not be used during pregnancy.
Administration
Cetrotide is administered by subcutaneous injection into the lower abdomen. The recommended dose is 0.25 mg given once daily, typically starting on day 5-6 of ovarian stimulation and continuing until the day of ovulation induction. The first dose should be given under medical supervision in case of allergic reactions. Subsequent doses can be self-administered by the patient, rotating the injection site each day.
The key benefits of Cetrotide are:
- Rapidly and reversibly suppresses luteinizing hormone (LH) to prevent premature ovulation during fertility treatments.
- No “flare phase” like older GnRH agonists, allowing shorter treatment duration.
- Highly effective at preventing premature LH surges in over 95% of patients.
- Convenient once-daily subcutaneous injection that can be self-administered.
- Rapid onset of action to immediately suppress LH secretion.
The key ingredients in Cetrotide are:
- Cetrorelix acetate – the active pharmaceutical ingredient that acts as a GnRH antagonist.
- Mannitol – an excipient included in the powder formulation.
- Water for injections – the solvent provided to reconstitute the powder.
The specific molecular structure and formula of cetrorelix, a synthetic decapeptide, enables its mechanism of action in preventing premature ovulation during fertility treatments.
Dosage: Cetrotide is dosed at 0.25 mg subcutaneously once daily, typically starting on day 5-6 of ovarian stimulation until ovulation induction. First dose requires medical supervision.          Storage: Cetrotide should be refrigerated at 2-8°C, protected from light. Reconstituted solution must be used immediately.                                                              Reviews: Cetrotide effectively prevents premature ovulation in over 95% of patients. Common side effects include injection site reactions. Overall, it is considered a safe and effective option for IVF protocols.
Reviews
There are no reviews yet.